Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: pressing need for validation clinical trials
- PMID: 20397005
- DOI: 10.1007/s00134-010-1883-8
Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: pressing need for validation clinical trials
Comment on
-
Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.Intensive Care Med. 2010 Jul;36(7):1147-55. doi: 10.1007/s00134-010-1879-4. Epub 2010 Apr 16. Intensive Care Med. 2010. PMID: 20397007
Similar articles
-
Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.Am J Respir Crit Care Med. 2000 Jul;162(1):328-30. doi: 10.1164/ajrccm.162.1.9910071. Am J Respir Crit Care Med. 2000. PMID: 10903263
-
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa.BMC Infect Dis. 2011 Nov 15;11:317. doi: 10.1186/1471-2334-11-317. BMC Infect Dis. 2011. PMID: 22085766 Free PMC article.
-
Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia.J Cyst Fibros. 2005 May;4(2):149-50. doi: 10.1016/j.jcf.2005.02.003. J Cyst Fibros. 2005. PMID: 15886070 No abstract available.
-
Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S89-94. doi: 10.1086/504485. Clin Infect Dis. 2006. PMID: 16894521 Review.
-
Comparison of different colistin regimens for the treatment of pneumonia caused by multidrug-resistant microorganisms: a systematic review and meta-analysis.Eur Rev Med Pharmacol Sci. 2021 Aug;25(16):5275-5292. doi: 10.26355/eurrev_202108_26549. Eur Rev Med Pharmacol Sci. 2021. PMID: 34486704
Cited by
-
Effects of amikacin, polymyxin-B, and sulbactam combination on the pharmacodynamic indices of mutant selection against multi-drug resistant Acinetobacter baumannii.Front Microbiol. 2022 Oct 20;13:1013939. doi: 10.3389/fmicb.2022.1013939. eCollection 2022. Front Microbiol. 2022. PMID: 36338049 Free PMC article.
-
Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1883-7. doi: 10.1007/s10096-011-1516-3. Epub 2011 Dec 25. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22198679
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical